DEVELOPMENT OF NEW ANALYTICAL METHODS FOR THE ESTIMATION OF OPIOID ANTAGONIST NALTREXONE HYDROCHLORIDE
|
|
- Tiffany Moore
- 5 years ago
- Views:
Transcription
1 114 P a g e International Standard Serial Number (ISSN): International Journal of Universal Pharmacy and Bio Sciences 4(1): January-February 2015 INTERNATIONAL JOURNAL OF UNIVERSAL PHARMACY AND BIO SCIENCES IMPACT FACTOR 2.093*** Pharmaceutical Sciences ICV 5.13*** RESEARCH ARTICLE!!! DEVELOPMENT OF NEW ANALYTICAL METHODS FOR THE ESTIMATION OF OPIOID ANTAGONIST NALTREXONE HYDROCHLORIDE Jabeen Farhana, Wajeed Khan, Vinayak K Durgakar, Asiya Begum KEYWORDS: Naltrexone hydrochloride; MBTH; Potassium ferricyanide; 1, 10 Phenanthroline; 2, 2' Bipyridyl; Folin- Ciocalteu reagent; RP- HPLC. For Correspondence: Asiya Begum * Address: CMR college of pharmacy, Moinabad. asiyabegum889@gmail.c om CMR college of pharmacy,moinabad. ABSTRACT In the present work, six simple and sensitive spectrophotometric methods (method A, B, C, D, E, F) and RP HPLC method have been developed for the quantitative determination of Naltrexone hydrochloride. Method A is a UV spectrophotometric method in which Naltrexone hydrochloride was dissolved in distilled water and distilled alcohol and it exhibited absorption maximum at 281 nm and obeyed Beer s law in the concentration range of g/ml. Method B based on oxidation followed by coupling of 3-methyl-2-benzothiazolinone hydrazone (MBTH) in presence of ferric chloride to form green colored chromogen. Method C, D and E is based on Oxidation followed by complex formation with potassium ferricyanide, 1,10-phenanthroline and 2, 2' Bipyridyl in presence of ferric chloride to form blue colored, blood red and orange red colored chromogen respectively. Method F is based on formation of stable blue colored chromogen due to reduction of Folin- ciocalteau reagent in presence of sodium hydroxide. The above methods were exhibited absorption maximum at 661, 715, 509.6, 520.8, 734 nm and obeying beers law in the concentration range of , 2-10, 2-10, 2-10 and 5-25 µg/ml respectively. In RP-HPLC mode the chromatographic separation was achieved by using column oyster C 18 (250 x 4.6mm, 5 ). The mobile phase consists of combination of ammonium acetate buffer (ph 5.8) and acetonitrile in the ratio 60:40 v/v respectively and was pumped at a rate of 1.0 ml/min at 30 0 C and the injection volume was 10 µl. The detection was carried out at 220nm and the calibration curve was linear in the range of µg/ml. Retention time was min. The correlation coefficient was found to be There was no significant difference in intra-day and inter-day analysis; the RSD value 0.769% indicates high precision of analytical method. The proposed methods are economical, simple, sensitive and accurate for quantitative determination of Naltrexone hydrochloride in bulk drug and pharmaceutical formulations.
2 115 P a g e International Standard Serial Number (ISSN): INTRODUCTION: Analytical chemistry is the science of making quantitative and qualitative measurements. In practice, quantifying an analyte in a complex sample becomes an exercise in problem solving. To be efficient and effective, an analytical chemist must know the tools that are available to tackle a wide variety of problems. Analytical chemistry is divided into two branches qualitative and quantitative. A qualitative method provides information about the identity of atomic or molecular species or functional groups in sample. A quantitative method provides numerical information as to the relative amount of one or more of the components 1, 2 Quality control is a concept, which strives to produce a perfect product by series of measures designed to prevent and eliminate errors at different stages of production. The decision to release or reject a product is based on one or more types of control action. With the growth of pharmaceutical industry during last several years, there has been rapid progress in the field of pharmaceutical analysis involving complex instrumentation. Providing simple analytical procedure for complex formulation is a matter of most importance. It becomes necessary, therefore, to develop new analytical method for such drugs. In brief the reasons for the development of newer methods of drugs analysis are: The drug or drug combination may not be official in any pharmacopoeias. A proper analytical procedure for the drug may not be available in the literature due to patent regulations. Analytical methods may not be available for estimation of drug in the form of formulation excipients. Pharmaceutical analysis deals not only with medicaments (drugs and formulations), but also with their precursors i.e. with the raw material whose degree of purity, which in turn decides the quality of medicaments. The quantity of a drug is determined, after establishing its authenticity, which is carried by testing its purity and the quality of the pure substance in the drug and its formulations. Varieties of analytical methods are used for the analysis of drugs in bulk, formulations and biological samples. In pharmaceutical industry, spectrophotometric and chromatographic methods have gained the significance in recent years.
3 116 P a g e International Standard Serial Number (ISSN): ULTRAVIOLET-VISIBLE ABSORPTION SPECTROSCOPY SPECTROPHOTOMETRIC METHODS It is defined as a method of analysis that embraces the measurement of absorption by chemical species of radiant energy at definite and narrow wavelength approximating monochromatic radiation. The fundamental law that governs the quantitative spectrophotometric analysis is the Beer- Lambert s law which is stated as; When a beam of monochromatic light is passed through a transparent cell containing a solution of an absorbing substance, reduction of intensity of the light may occurs; the rate of reduction in intensity with the thickness of the medium is proportional to the intensity of the light and the concentration of the absorbing substances. Mathematically Beer-Lamberts law is expressed as; A = a b c Where, A = absorbance or optical density, a = absorptivity or extinction coefficient, b = path length of radiation through sample (cm), c = concentration of solute in solution. This deals with the absorption of electromagnetic radiation in the wavelength region of 160 to 780 nm. UV absorption spectroscopy deals with absorption of light by a sample in the Ultra Violet (UV) region ( nm), while Visible region ( nm). Absorption spectroscopy (colorimetry) deals with absorption of light by a sample in the visible region ( nm). Currently, research grade UV-VIS absorption instruments come in two configurations. The first is called scanning spectrophotometer because it measures the intensity of transmitted light of a narrow band pass, and scans the wavelength in time in order to collect a spectrum. Because absorption is a ratiometric measurement, these instruments generally require the user to measure two spectra, one sample and one blank. The blank should be identical to the sample in every way except that the absorbing species of interest is not present. This can be done either consecutively with a single beam instrument followed by the ratio calculation, or simultaneously with a dual beam instrument. The dual beam method is faster, and has the added advantage that lamp drift and other slow intensity fluctuations are properly accounted for in the
4 117 P a g e International Standard Serial Number (ISSN): DRUG PROFILE Naltrexone hydrochloride is an opioid receptor antagonist used primarily in the management of alcohol dependence and opioid dependence. It is marketed as generic from as its hydrochloride salt, Naltrexone Hydrochloride 18. It is official in Martindale 19, Merck Index 20, USP 21,.BP 22. Chemical structure : Chemical Name : (5α)-17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxy morphinan -6-one hydrochloride. Empirical formula : C 20 H 23 N0 4.HCl Molecular weight : Physical properties : A white or almost white, very hygroscopic powder. Melting point : c Solubility : It is freely soluble in water; slightly soluble in alcohol, practically insoluble in dichloromethane. Storage : Store at room temperature in a cool place. Protect from light. Mechanism of action Naltrexone binds to the opioid mu (µ) receptor antagonistically, thereby preventing conventional opiate (heroin, morphine) drugs from binding and inducing opioid neural responses. The mechanism of action of Naltrexone in alcoholism is not understood; however, involvement of the endogenous opioid system is suggested by preclinical data. Naltrexone competitively binds to such receptors and may block the effects of endogenous opioids. Pharmacological action Opioid receptor antagonist markedly attenuating or completely blocking, reversibly, the subjective effects of IV administered opioids.
5 118 P a g e International Standard Serial Number (ISSN): Indications and Usage Alcohol dependence; blockade of exogenously administered opioids (oral); treatment of alcohol dependence in patients able to abstain from alcohol in an outpatient setting (IM injection). Unlabeled Uses Eating disorders; postconcussional syndrome unresponsive to other treatments. DRUG PROFILE Naltrexone hydrochloride is an opioid receptor antagonist used primarily in the management of alcohol dependence and opioid dependence. It is marketed as generic from as its hydrochloride salt, Naltrexone Hydrochloride 18. It is official in Martindale 19, Merck Index 20, USP 21,.BP 22. Chemical structure : Chemical Name : (5α)-17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxy morphinan -6-one hydrochloride. Empirical formula : C 20 H 23 N0 4.HCl Molecular weight : Physical properties : A white or almost white, very hygroscopic powder. Melting point : c Solubility : It is freely soluble in water; slightly soluble in alcohol, practically insoluble in dichloromethane. Storage : Store at room temperature in a cool place. Protect from light. Mechanism of action Naltrexone binds to the opioid mu (µ) receptor antagonistically, thereby preventing conventional opiate (heroin, morphine) drugs from binding and inducing opioid neural responses. The mechanism of action of Naltrexone in alcoholism is not understood; however, involvement of the endogenous opioid system is suggested by preclinical data. Naltrexone competitively binds to such receptors and may block the effects of endogenous opioids.
6 119 P a g e International Standard Serial Number (ISSN): Pharmacological action Opioid receptor antagonist markedly attenuating or completely blocking, reversibly, the subjective effects of IV administered opioids. Indications and Usage Alcohol dependence; blockade of exogenously administered opioids (oral); treatment of alcohol dependence in patients able to abstain from alcohol in an outpatient setting (IM injection). Unlabeled Uses Eating disorders; postconcussional syndrome unresponsive to other treatments. UV-VISIBLE SPECTROPHOTOMETERIC METHODS. Method A : Uv Spectrophotometeric Method (Reference Method By Cosolvancy ). Method B : Visible Spectrophotometeric Method By Using Mbth Reagent. Method C : Visible Spectrophotometeric Method By Using Potassium Ferricyanide Reagent. Method D : Visible Spectrophotometeric Method By Using 1,10 Phenanthroline Reagent. Method E : Visible Spectrophotometeric Method By Using 2,2' Bipyridyl Reagent. Method F : Visible Spectrophotometeric Method By Using Folin Cio-Calteu Reagent. INSTRUMENTS USED 1. A systronics 119 UV/visible spectrophotometer with 1 cm matched quartz cells were used. CHEMICALS AND REAGENTS: All chemicals and reagent used were of Analytical grade. Sr. No. Name Source 1. Distilled ethanol SD Fine Chemical, Mumbai. 2. Ferric chloride SD Fine Chemical, Mumbai. 3. MBTH Loba Chemicals, Mumbai. 4. Potassium Ferricyanide SD Fine Chemical, Mumbai. 5. 1, 10 Phenanthroline SD Fine Chemical, Mumbai. 6. 2, 2' Bipyridyl Qualigens, Mumbai. 7. Folin-Ciocalteu reagent (FC) Loba Chemicals, Mumbai. 8. Sodium Hydroxide Qualigens, Mumbai. Bulk drug of Naltrexone Hydrochloride was obtained from Intas Pharmaceutical Pvt Ltd, Ahmedabad. Formulations of Naltrexone Hydrochloride used for the study are Naltima (Intas pharma Pvt. Ltd) and Nodict (Sun Pharm Ltd) both containing 50 mg were procured from local market.
7 120 P a g e International Standard Serial Number (ISSN): Preparation of Reagents 1. 1% aqueous Ferric chloride solution 1 gm of ferric chloride reagent was accurately weighed and dissolved in distilled water in 100mL volumetric flask, volume was made upto the mark with distilled water % aqueous Ferric chloride solution 0.5 gm of ferric chloride reagent was accurately weighed and dissolved in distilled water in 100mL volumetric flask, volume was made upto the mark with distilled water % aqueous Ferric chloride solution 0.4 gm of ferric chloride reagent was accurately weighed and dissolved in distilled water in 100mL volumetric flask, volume was made upto the mark with distilled water % aqueous MBTH Reagent solution 0.5 gm of MBTH reagent was accurately weighed and dissolved in distilled water in 100mL volumetric flask, volume was made upto the mark with distilled water % aqueous Potassium ferricyanide solution 0.1 gm of potassium ferricyanide was accurately weighed and dissolved in distilled water in 100mL volumetric flask, volume was made upto the mark with distilled water % alcoholic 1, 10 Phenanthroline solution 0.2 gm of 1, 10 phenanthroline reagent was accurately weighed and dissolved in distilled ethanol in 100mL volumetric flask, volume was made upto the mark with distilled ethanol % alcoholic 2, 2' Bipyridyl solution 0.2 gm of 2, 2' Bipyridyl reagent was accurately weighed and dissolved in distilled ethanol in 100mL volumetric flask, volume was made upto the mark with distilled ethanol. 8. 1N FC Reagent solution The available 2N FC reagent is diluted in the ratio of 1:1 with distilled water. 9.1N aqueous Sodium Hydroxide solution 4 gm of sodium hydroxide was accurately weighed and dissolved in distilled water in 100 ml volumetric flask, volume was made upto the mark with distilled water. METHOD A (UV Spectrophotometric method; Reference method by Cosolvancy). A. Preparation of standard calibration curve of bulk drug. 1. Solvent Used Distilled water and ethanol were used as solvent.
8 121 P a g e International Standard Serial Number (ISSN): Preparation of standard stock solution Accurately weighed 100 mg of Naltrexone Hydrochloride (bulk drug or its formulation) was dissolved in 40 ml of distilled water in 100mL volumetric flask and volume was made upto the mark with distilled ethanol (i.e.1000 µg/ml). 3. Preparation of calibration curve Fresh aliquots of Naltrexone Hydrochloride ranging from 0.5 to 2.5 ml (1 ml-1000µg/ml) were transferred into a series of 10 ml volumetric flasks to provide final concentration range of 50 to 250 μg/ml. The solution in each tube were made upto the mark with distilled ethanol. The absorbance of solution was measured at 281 nm against the reagent blank (Figure 3.1). The amount of Naltrexone Hydrochloride present in the sample solution was computed from its calibration curve (Figure 3.2). B. Analysis of tablet formulation The sample of the powder tablet claimed to contain 50 mg. The accurate quantity equivalent to 100 mg of active ingredient was extracted with distilled water (3 x 15 ml) and filtered through a µm membrane filter, followed by adding distilled ethanol upto 100 ml to get the stock solution of 1 mg/ml. Subsequent dilutions of this solution were made with distilled ethanol to get concentration of µg/ml and were prepared as above and analyzed at the selected analytical wavelengths, 281 nm and their results were statically validated.
9 122 P a g e International Standard Serial Number (ISSN): METHOD A (UV SPECTROPHOTOMETERIC METHOD BY COSOLVANCY) Figure 3.1:- Absorption spectra for Naltrexone hydrochloride in distilled water and alcohol (150 g/ml, λmax 281 nm) Figure 3.2:- Calibration curve for Naltrexone hydrochloride at 281 nm with distilled water and ethanol Table 3.1:- Data for absorption spectrum of Naltrexone hydrochloride for UV method (Drug concentration = 150 g/ml)
10 123 P a g e International Standard Serial Number (ISSN): Table 3.2:- Result of calibration curve for Naltrexone hydrochloride by UV spectroscopy Concentration Absorbance (μg/ml) Mean ± S.D* % CV ± ± ± ± ± ± *Average of three determinations. Table 3.3:- Optical characteristic and precision by UV spectroscopy UV(BY COSOLVANCY Parameter METHOD) max (nm) 281 Beer s law limits ( g/ml) (c) Molar absorptivity (lit. mol -1 cm -1 ) x 10 3 Limit of Detection (LOD/ mcgml -1 ) 3.23 Limit of Quantification (LOQ/ mcgml -1 ) 9.79 Sandell s sensitivity ( g/ml abs unit) Regression equation (Y*) Slope (b) x 10-3 Intercept (a) 3 x 10-4 Standard error of estimation (Se) Correlation coefficient (r) % RSD Range of Errors** Confidence limit with 0.05 level Confidence limit with 0.01 level % Error in bulk Samples*** *Y=bC+a, where C is the concentration of Naltrexone hydrochloride in g/ml and Y is the absorbance at the respective maximum absorbency, **Average of eight determination, ***Average of three determination.
11 124 P a g e International Standard Serial Number (ISSN): Table 3.4:- Assay and Recovery of Naltrexone hydrochloride in Pharmaceutical dosage form (Tablet) by UV Method Sample Labeled amount (mg) Amount obtained (mg) Proposed method* % recovery T T T1 and T2 are tablets from different manufactures, *Average of 5 determinations (50 mg of Naltrexone hydrochloride was added and recovered). Table 3.5:- Determination of Accuracy of Naltrexone hydrochloride Level of % Recovery Amount of drug in Formulation* (mg) Amount of standard drug added (mg) Total amount of drug found (mg) % Recovery of pure drug 80 % % % *Pre-analyzed sample taken from T 1 and T 2. Table 3.6:- Statistical data for accuracy determination Level of % Recovery Total amount found (mg) Mean* Standard deviation* Coefficient of variation* (%) Standard error* 80 % % % *The results are the mean of three readings at each level of recovery.
12 125 P a g e International Standard Serial Number (ISSN): Table 3.7:- Repeatability Data for Naltrexone hydrochloride at 281nm Concentration Std. Abs 1 Abs 2 Abs 3 Mean (μg/ml) Deviation* *Average of three determinations. METHOD B (Visible Spectrophotometric method by MBTH Reagent). EXPERIMENTAL A. Preparation of standard calibration curve of bulk drug. 1. Solvent Used Distilled ethanol and distilled water were used as solvent. 2. Preparation of standard stock solution Accurately weighed 100 mg of Naltrexone Hydrochloride (bulk drug or its formulation) was dissolved in 40 ml of distilled water in 100mL volumetric flask and volume was made upto the mark with distilled ethanol (i.e.1000 µg/ml). 3. Preparation of calibration curve Fresh aliquots of Naltrexone Hydrochloride ranging from 0.2 to 1 ml (1 ml-1000 µg/ml) were transferred into a series of 10 ml volumetric flasks to provide final concentration range of 20 to 100 µg/ml. To each flask 1 ml of aqueous ferric chloride (1 %) solution and 0.2 ml of MBTH reagent (0.5% in distilled water) were added. Aliquotes were kept aside for 10 mins. The solutions in each tube were made upto mark with distilled water. The absorbance of green colored chromogen was measured at 661 nm against the reagent blank (Figure 3.3). The color species was stable for 1.2 hour. The amount of Naltrexone Hydrochloride present in the sample solution was computed from its calibration curve (Figure 3.4). B. Analysis of tablet formulation The sample of the powder tablet claimed to contain 50 mg. The accurate quantity equivalent to 100 mg of active ingredient was extracted with distilled water (3 x 15mL) and filtered through a µm membrane filter, followed by adding distilled ethanol upto 100mL to get the stock
13 126 P a g e International Standard Serial Number (ISSN): solution of 1 mg/ml. Subsequent dilutions of this solution were made with distilled water to get concentration of µg/ml and were prepared as above and analyzed at the selected analytical wavelengths, 661 nm and their results were statically validated. Figure 3.3:- Absorption spectra for Naltrexone hydrochloride by using MBTH reagent (60 g/ml, λmax 661nm) Figure3.4:- Calibration curve for Naltrexone hydrochloride at 661 nm with 1% FeCl 3 and 0. 5% MBTH reagent Table3.8:- Data for absorption spectrum of Naltrexone hydrochloride for MBTH method (Drug concentration = 60 g/ml) Wavelength (nm) Absorbance
14 127 P a g e International Standard Serial Number (ISSN): Table3.9:- Result of calibration curve for Naltrexone by MBTH reagent method Concentration Absorbance (μg/ml) Mean ± S.D* % CV ± ± ± ± ± ± *Average of three determinations. Table3.10:- Optical characteristic and precision by MBTH Method Parameter max (nm) 661 Beer s law limits ( g/ml) (c) MBTH Method Molar absorptivity (lit. mol -1 cm -1 ) x 10 4 Limit of Detection (LOD/ mcgml -1 ) Limit of Quantification (LOQ/ mcgml -1 ) 1.52 Sandell s sensitivity ( g/ml abs unit) Regression equation (Y*) Slope (b) Intercept (a) x 10-4 Standard error of estimation (Se) Correlation coefficient (r) % RSD Range of Errors** Confidence limit with 0.05 level Confidence limit with 0.01 level % Error in bulk Samples*** 2.27 *Y=bC+a, where C is the concentration of Naltrexone hydrochloride in g/ml and Y is the absorbance at the respective maximum absorbency, **Average of eight determination, ***Average of three determination.
15 128 P a g e International Standard Serial Number (ISSN): Table3.11:-Assay and Recovery of Naltrexone hydrochloride in Pharmaceutical dosage form (Tablet) by MBTH Method Sample Labeled amount (mg) Amount obtained* (mg) Proposed Method Reference method (UV Method by cosolvancy) % recovery T T T1 and T2 are tablets from different manufactures, *Average of 5 determinations (50 mg of Naltrexone hydrochloride was added and recovered). Table3.12:- Determination of Accuracy of Naltrexone hydrochloride Level of % Recovery Amount of drug in formulation* (mg) Amount of standard drug added (mg) Total amount Of drug found(mg) % Recovery of pure drug % % % *Pre-analyzed sample taken from T 1 and T 2. Table3.13:- Statistical data for Accuracy determination Level of % Recovery Total amount found (mg) Mean* Standard deviation* Coefficient of variation* (%) Standard error* 80 % % % *The results are the mean of three readings at each level of recovery.
16 129 P a g e International Standard Serial Number (ISSN): Table3.14:- Repeatability Data for Naltrexone hydrochloride at 661 nm Concentration Std. Abs 1 Abs 2 Abs 3 Mean (μg/ml) Deviation* *Average of three determinations. Nature of colored Species An attempt has been made to indicate the nature of colored species in the proposed method for Naltrexone hydrochloride (which contain phenolic hydroxyl group), tentatively based on analogy (reactive functional groups in drug, reagents nature) and probability (relative reactivities and impact of functional moieties one over the other). This method is based on the oxidative coupling of Naltrexone hydrochloride with MBTH in the presence of ferric chloride. MBTH on oxidation with ferric chloride looses two electrons and one proton to form an electrophilic intermediate, which is the active coupling species, reacts with the coupler (Naltrexone hydrochloride) by electrophilic attack on the most nucleophilic site of Naltrexone hydrochloride to form a bluish green colored species (as shown in Scheme-3.1) with absorption maximum at 661 nm (Figure-3.3) and Beer s law is obeyed in the concentration range of g/ml (Figure-3.4.).
17 130 P a g e International Standard Serial Number (ISSN): Naltrexone hydrochloride reaction with MBTH Scheme 3.1 METHOD C (Visible Spectrophotometric method by Potassium ferricyanide) EXPERIMENTAL A. Preparation of standard calibration curve of bulk drug. 1. Solvent Used Distilled water and ethanol are used as solvent. 2. Preparation of standard stock solution Accurately weighed 100 mg of Naltrexone Hydrochloride (bulk drug or its formulation) was dissolved in 40 ml of distilled water in 100 ml volumetric flask and volume was made upto the mark with distilled ethanol (i.e.1000 µg/ml). Stock solution A.
18 131 P a g e International Standard Serial Number (ISSN): From the above stock solution A 10 ml of solution was pipetted out in 100 ml volumetric flask and the volume was made up to the mark with distilled ethanol to obtain the final concentration of 100 µg/ml. Stock solution B. 3. Preparation of calibration curve Fresh aliquots of Naltrexone Hydrochloride ranging from 0.2 to 1.0 ml (1 ml-1000µg/ml) were transferred into a series of 10 ml volumetric flasks to provide final concentration range of 2 to 10 μg/ml. To each flask 1ml of aqueous Ferric chloride (1%) solution and 1 ml of potassium ferricyanide (0.1% in distilled water) were added. The solution in each tube were made upto the mark with distilled water. The absorbance of bluish green colored chromogen was measured at 715 nm against the blank (Figure 3.5). The color species was stable for one hour. The amount of Naltrexone Hydrochloride present in the sample solution was computed from its calibration curve (Figure 3.6). B. Analysis of tablet formulation The sample of the powder tablet claimed to contain 50 mg. The accurate quantity equivalent to 100 mg of active ingredient was extracted with distilled water (3 x 15mL) and filtered through a µm membrane filter, followed by adding distilled ethanol upto 100mL to get the stock solution of 1 mg/ml. Subsequent dilutions of this solution were made with distilled water to get concentration of 2-10 µg/ml and were prepared as above and analyzed at the selected analytical wavelengths, 715 nm and their results were statically validated.
19 132 P a g e International Standard Serial Number (ISSN): Figure3.5:- Absorption spectra for Naltrexone hydrochloride by using potassium ferricyanide and ferric chloride (6 g/ml, λmax 715 nm) Figure3.6:- Calibration curve for Naltrexone hydrochloride at 715 nm with 1% FeCl 3 and 0.1% potassium ferricyanide reagent Table3.15:-Data for absorption spectrum of Naltrexone hydrochloride for potassium ferricyanide method (Drug concentration = 6 g/ml) Wavelength (nm) Absorbance
20 133 P a g e International Standard Serial Number (ISSN): Table 3.16:- Result of calibration curve for Naltrexone hydrochloride by Potassium ferricyanide method Concentration Absorbance (μg/ml) Mean ± S.D* % CV ± ± ± ± ± ± *Average of three determinations. Table 3.17:- Optical characteristic and precision by potassium ferricyanide method Parameter Potassium ferricyanide method max (nm) 715 Beer s law limits ( g/ml) (c) 2-10 Molar absorptivity (lit. mol -1 cm -1 ) x 10 3 Limit of Detection (LOD/ mcgml -1 ) Limit of Quantification (LOQ/ mcgml -1 ) Sandell s sensitivity ( g/ml abs unit) Regression equation (Y*) Slope (b) Intercept (a) x 10-4 Standard error of estimation (Se) Correlation coefficient (r) % RSD Range of Errors** Confidence limit with 0.05 level Confidence limit with 0.01 level % Error in bulk Samples*** *Y=bC+a, where C is the concentration of Naltrexone hydrochloride in g/ml and Y is the absorbance at the respective maximum absorbency, **Average of eight determination, ***Average of three determination.
21 134 P a g e International Standard Serial Number (ISSN): Table 3.18:- Assay and Recovery of Naltrexone hydrochloride in Pharmaceutical dosage form (Tablet) by potassium ferricyanide method Sample Labeled amount (mg) Amount obtained* (mg) Proposed Method Reference method (UV Method by cosolvancy) % recovery T T T1 and T2 are tablets from different manufactures, *Average of 5 determinations (50 mg of Naltrexone hydrochloride was added and recovered). Table 19:- Determination of Accuracy of Naltrexone hydrochloride Level of % Recovery Amount Of drug in formulation* (mg) Amount of standard drug added (mg) Total amount Of drug found (mg) % Recovery of pure drug % % % *Pre-analyzed sample taken from T 1 and T 2. Level of % Recovery Table 3.20:- Statistical data for Accuracy determination Total amount found (mg) Mean* Standard deviation* Coefficient of variation* (%) Standard error* 80 % % % *The results are the mean of three readings at each level of recovery.
22 135 P a g e International Standard Serial Number (ISSN): Table 3.21:- Repeatability Data for Naltrexone hydrochloride at 715 nm Concentration Std. Abs 1 Abs 2 Abs 3 Mean (μg/ml) Deviation* *Average of three determinations. Nature of Colored species An attempt has been made to indicate the nature of colored species in the proposed method for Naltrexone hydrochloride (which contain phenolic hydroxyl group), tentatively based on analogy (reactive functional groups in drug, reagents nature) and probability (relative reactivities and impact of functional moieties one over the other). This method is based on the reaction of drug with ferric chloride and potassium ferricyanide, which forms blue colored chromogens (as shown in scheme-3.2) exhibiting absorption maximum at 715 nm (Fig.-3.5) against reagent blank and obeyed Beer s law in the concentration range of 2-10 g/ml (Fig.-3.6). In this method, Naltrexone hydrochloride exhibits reducing property due to the presence of functional moieties (one or more) vulnerable to oxidation selectively with oxidizing agents such as Fe (III) under controlled experimental conditions when treated with known excess of oxidant, Naltrexone hydrochloride undergoes oxidation, giving products of oxidation [inclusive of reduced form of oxidant Fe (II) from Fe (III)] besides unreacted oxidant. It is possible to estimate the drug content colorimetrically, which is equivalent to either reduced oxidant or reduced form of oxidant formed. The reduced form of Fe (III) (i.e., Fe (II) has a tendency to give a colored complex on treatment with K 3 Fe [(CN) 6 ] 3-. Reaction of Naltrexone hydrochloride with Potassium ferricyanide Naltrexone hydrochloride + Fe (III) Oxidation products + Fe (III) + Unreacted Fe (III) 3 Fe [ Fe (CN) 6 ] -3 Fe 3 [ Fe (CN) 6 ] 2 Scheme 3.2
23 136 P a g e International Standard Serial Number (ISSN): METHOD D (Visible Spectrophotometric method by 1, 10 Phenanthroline) EXPERIMENTAL A. Preparation of standard calibration curve of bulk drug. 1. Solvent Used Distilled water is used as solvent. 2. Preparation of standard stock solution Accurately weighed 100 mg of Naltrexone Hydrochloride (bulk drug or its formulation) was dissolved in 40 ml of distilled water in 100 ml volumetric flask and volume was made upto the mark with distilled water (i.e.1000 µg/ml). Stock solution A. From the above stock solution A 10 ml of solution was pipetted out in 100 ml volumetric flask and the volume was made up to the mark with distilled water to obtain the final concentration of 100 µg/ml. Stock solution B. 3. Preparation of calibration curve Fresh aliquots of Naltrexone Hydrochloride ranging from 0.2 to 10 ml (1 ml-100µg/ml) were transferred into a series of 10 ml volumetric flasks to provide final concentration range of 2 to 10 μg/ml. To each flask 0.5 ml of ferric chloride (0.4%) solution and 1 ml of alcoholic 1, 10 phenanthroline (0.2%) were added and heated at 40 0 C for 10 mins. The solutions were cooled to room temperature and made upto the mark with distilled water. The absorbance of blood red colored chromogen was measured at nm against the reagent blank (Figure 3.7). The color species was stable for 1.2 hour. The amount of Naltrexone Hydrochloride present in the sample solution was computed from its calibration curve (Figure 3.8). B. Analysis of tablet formulation The sample of the powder tablet claimed to contain 50 mg. The accurate quantity equivalent to 100 mg of active ingredient was extracted with distilled water (3 x 15mL) and filtered through a µm membrane filter, followed by adding distilled water upto 100mL to get the stock solution of 1 mg/ml. Subsequent dilutions of this solution were made with distilled water to get concentration of 2-10 µg/ml and were prepared as above and analyzed at the selected analytical wavelengths, nm and their results were statically validated.
24 137 P a g e International Standard Serial Number (ISSN): Figure 3.7:- Absorption spectra for Naltrexone hydrochloride by 1, 10 Phenanthroline reagent (6 g/ml, λmax nm) Figure 3.8:- Calibration curve for Naltrexone hydrochloride at nm by ferric chloride (0.4%) and 1, 10 Phenanthroline reagent (0.2%) Table 3.22:- Data for absorption spectrum of Naltrexone hydrochloride for 1, 10 Phenanthroline method (Drug concentration = 150 g/ml) Wavelength (nm) Absorbance
25 138 P a g e International Standard Serial Number (ISSN): Table 3.23:- Result of calibration curve for Naltrexone hydrochloride by 1, 10 Phenanthroline method Concentration Absorbance (μg/ml) Mean ± S.D* % CV ± ± ± ± ± ± *Average of three determinations. Table 3.24:- Optical characteristic and precision by 1, 10 Phenanthroline method Parameter 1, 10 Phenanthroline method max (nm) Beer s law limits ( g/ml) (c) 2-10 Molar absorptivity (lit. mol -1 cm -1 ) x 10 4 Limit of Detection (LOD/ mcgml -1 ) Limit of Quantification (LOQ/ mcgml -1 ) Sandell s sensitivity ( g/ml abs unit) Regression equation (Y*) Slope (b) Intercept (a) x 10-4 Standard error of estimation (Se) Correlation coefficient (r) % RSD Range of Errors** Confidence limit with 0.05 level Confidence limit with 0.01 level % Error in bulk Samples*** 0.12 *Y=bC+a, where C is the concentration of Naltrexone hydrochloride in g/ml and Y is the absorbance at the respective maximum absorbency, **Average of eight determination, ***Average of three determination.
26 139 P a g e International Standard Serial Number (ISSN): Table 3.25:- Assay and Recovery of Naltrexone hydrochloride in Pharmaceutical dosage form (Tablet) by 1, 10 Phenanthroline reagent method. Sample Labeled amount (mg) Amount obtained* (mg) Proposed Method Reference method (UV Method by cosolvancy) % recovery T T T1 and T2 are tablets from different manufactures, *Average of 5 determinations (50 mg of Naltrexone hydrochloride was added and recovered). Table 3.26:- Determination of Accuracy of Naltrexone hydrochloride Level of % Recovery Amount Of drug in formulation* (mg) Amount of standard drug added (mg) Total amount Of drug found (mg) % Recovery of pure drug % % % *Pre-analyzed sample taken from T 1 and T 2. Table 3.27:- Statistical data for Accuracy determination Level of % Recovery Total amount found (mg) Mean* Standard deviation* Coefficient of variation* (%) Standard error* 80 % % % *The results are the mean of three readings at each level of recovery.
27 140 P a g e International Standard Serial Number (ISSN): Table 3.28:- Repeatability Data for Naltrexone hydrochloride at nm Concentration (μg/ml) Abs 1 Abs 2 Abs 3 Mean Std. Deviation* *Average of three determinations. Nature of Colored Species An attempt has been made to indicate the nature of colored species in the proposed method for Naltrexone hydrochloride (which contain phenolic hydroxyl group), tentatively based on analogy (reactive functional groups in drug, reagents nature) and probability (relative reactivities and impact of functional moieties one over the other). In this method Naltrexone hydrochloride was made to react with excess of ferric chloride under specified experimental conditions into ferrous salt, the amount of conversion corresponds to the drug concentration. The ferrous ions thus formed in the reactions were made to react with 1,10 PTL to form blood red colored complex (as shown in scheme 3.3) due to the formation of six coordinate bonds between ferrous ion and six nitrogen atoms of three molecules of 1,10 PTL which have got a lone pair of electron each, with absorption maximum ( max) at nm (Fig.- 3.7) and obeyed Beer s law in the concentration range of 2-10 g/ml (Fig.-3.8). The first step in the method is the oxidation of Naltrexone hydrochloride with oxidant. Naltrexone hydrochloride + Fe (III) Oxidation products + Fe (II). The second step concerns with the estimation of Fe (II) with 1,10-PTL. Reaction of Naltrexone hydrochloride with 1,10-Phenanthroline Scheme 3.3
28 141 P a g e International Standard Serial Number (ISSN): METHOD E (Visible Spectrophotometric method by 2,2' Bipyridyl) EXPERIMENTAL A. Preparation of standard calibration curve of bulk drug. 1. Solvent Used Distilled water is used as solvent. 2. Preparation of standard stock solution Accurately weighed 100 mg of Naltrexone Hydrochloride (bulk drug or its formulation) was dissolved in 40 ml of distilled water in 100 ml volumetric flask and volume was made upto the mark with distilled water (i.e.1000 µg/ml). Stock solution A. From the above stock solution A 10 ml of solution was pipetted out in 100 ml volumetric flask and the volume was made up to the mark with distilled water to obtain the final concentration of 100 µg/ml. Stock solution B. 3. Preparation of calibration curve Fresh aliquots of Naltrexone Hydrochloride ranging from 0.2 to 10 ml (1 ml-100µg/ml) were transferred into a series of 10 ml volumetric flasks to provide final concentration range of 2 to 10 μg/ml. To each flask 0.5 ml of ferric chloride (0.5%) solution and 0.5 ml of alcoholic 2, 2' Bipyridyl (0.2%) were added and heated at 40 0 C for 20 mins. The solutions were cooled to room temperature and made upto the mark with distilled water. The absorbance of orange red colored chromogen was measured at nm against the reagent blank (Figure 3.9). The color species was stable for 1.2 hour. The amount of Naltrexone Hydrochloride present in the sample solution was computed from its calibration curve (Figure 3.10). B. Analysis of tablet formulation The sample of the powder tablet claimed to contain 50 mg. The accurate quantity equivalent to 100 mg of active ingredient was extracted with distilled water (3 x 15mL) and filtered through a µm membrane filter, followed by adding distilled water upto 100mL to get the stock solution of 1 mg/ml. Subsequent dilutions of this solution were made with distilled water to get concentration of 2-10 µg/ml and were prepared as above and analyzed at the selected analytical wavelengths, nm and their results were statically validated.
29 142 P a g e International Standard Serial Number (ISSN): Figure 3.9:- Absorption spectra for Naltrexone hydrochloride by 2, 2' Bipyridyl method (6 g/ml, λmax nm) Figure 3.10:- Calibration curve for Naltrexone hydrochloride at 520.8nm by Ferric chloride (0.5%) and 2, 2' Bipyridyl (0.2%) 3.29:- Data for absorption spectrum of Naltrexone Table hydrochloride for 2, 2' Bipyridyl (Drug concentration = 150 g/ml) Wavelength (nm) Absorbance
30 143 P a g e International Standard Serial Number (ISSN): Table 3.30:- Result of calibration curve for Naltrexone hydrochloride by 2, 2' Bipyridyl method Concentration Absorbance (μg/ml) Mean ± S.D* % CV ± ± ± ± ± ± *Average of three determinations. Table 3.31:- Optical characteristic and precision by 2, 2' Bipyridyl method Parameter max (nm) Beer s law limits ( g/ml) (c) , 2' Bipyridyl method Molar absorptivity (lit. mol -1 cm -1 ) x 10 4 Limit of Detection (LOD/ mcgml -1 ) 3.60 Limit of Quantification (LOQ/ mcgml -1 ) Sandell s sensitivity ( g/ml abs unit) Regression equation (Y*) Slope (b) Intercept (a) Standard error of estimation (Se) Correlation coefficient (r) % RSD Range of Errors** Confidence limit with 0.05 level Confidence limit with 0.01 level % Error in bulk Samples*** *Y=bC+a, where C is the concentration of Naltrexone hydrochloride in g/ml and Y is the absorbance at the respective maximum absorbency, **Average of eight determination, ***Average of three determination.
31 144 P a g e International Standard Serial Number (ISSN): Table 3.32:- Assay and Recovery of Naltrexone hydrochloride in Pharmaceutical dosage form (Tablet) by 2, 2' Bipyridyl method Amount obtained* (mg) Sample Labeled amount (mg) Proposed Method Reference method (UV Method by cosolvancy) % recovery T T T1 and T2 are tablets from different manufactures, *Average of 5 determinations (50 mg of Naltrexone hydrochloride was added and recovered). Level of % Recovery 80 % 100 % 120 % Table 3.33:- Determination of Accuracy of Naltrexone hydrochloride Amount Of drug in formulation* (mg) *Pre-analyzed sample taken from T 1 and T 2. Amount of standard drug added (mg) Total amount Of drug found (mg) % Recovery of pure drug
32 145 P a g e International Standard Serial Number (ISSN): Level of % Recovery Table 3.34:- Statistical data for Accuracy determination Total amount found (mg) Mean* Standard deviation* Coefficient of variation* (%) Standard error* 80 % % % *The results are the mean of three readings at each level of recovery. Table 3.35:- Repeatability Data for Naltrexone hydrochloride at nm Concentration (μg/ml) Abs 1 Abs 2 Abs 3 Mean Std. Deviation* *Average of three determinations. Nature of Colored Species An attempt has been made to indicate the nature of colored species in the proposed method for Naltrexone hydrochloride (which contain phenolic hydroxyl group), tentatively based on analogy (reactive functional groups in drug, reagents nature) and probability (relative reactivities and impact of functional moieties one over the other). This method was also worked out on the principle where 2,2'-bipyridyl forms complex with ferric (III) ions followed by the oxidation of the drug by this complex which results into the formation of orange red colored chromogen (as shown in scheme-3.4). This colored species exhibited absorption maxima ( max) at nm (Fig.-3.9) and Beer s law is obeyed in the concentration range of 2-10 g/ml (Fig ). The first step in the methods mentioned above is the oxidation of Naltrexone hydrochloride with oxidant. Naltrexone hydrochloride + Fe (III) Oxidation products + Fe (II) The second step concerns with the estimation of Fe (II) with 2,2'-BPL.
33 146 P a g e International Standard Serial Number (ISSN): Reaction of Naltrexone hydrochloride with 2,2'-Bipyridyl Scheme 3.4 METHOD F (Visible Spectrophotometric method by FC reagent) EXPERIMENTAL A. Preparation of standard calibration curve of bulk drug. 1. Solvent Used Distilled water is used as solvent. 2. Preparation of standard stock solution Accurately weighed 100 mg of Naltrexone Hydrochloride (bulk drug or its formulation) was dissolved in 40 ml of distilled water in 100 ml volumetric flask and volume was made upto the mark with distilled water (i.e.1000 µg/ml). Stock solution A. From the above stock solution A 10 ml of solution was pipetted out in 100 ml volumetric flask and the volume was made up to the mark with distilled water to obtain the final concentration of 100 µg/ml. Stock solution B. 3. Preparation of calibration curve Fresh aliquots of Naltrexone Hydrochloride ranging from 0.5 to 2.5 ml (1 ml-100µg/ml) were transferred into a series of 10 ml volumetric flasks to provide final concentration range of 5 to 25 μg/ml. To each flask 1 ml of aqueous sodium hydroxide (1 N) solution and 0.5 ml of FC reagent (1N) were added. The solutions were cooled to room temperature and made upto the mark with distilled water. The absorbance of blue colored chromogen was measured at 734 nm against the reagent blank (Figure 3.11). The color species was stable for 1.2 hour. The amount of Naltrexone Hydrochloride present in the sample solution was computed from its calibration curve (Figure 3.12).
34 147 P a g e International Standard Serial Number (ISSN): A. Analysis of tablet formulation The sample of the powder tablet claimed to contain 50 mg. The accurate quantity equivalent to 100 mg of active ingredient was extracted with distilled water (3 x 15mL) and filtered through a µm membrane filter, followed by adding distilled water upto 100mL to get the stock solution of 1 mg/ml. Subsequent dilutions of this solution were made with distilled water to get concentration of 5-25 µg/ml and were prepared as above and analyzed at the selected analytical wavelengths, 734 nm and their results were statistically validated. Figure 3.11:- Absorption spectra for Naltrexone hydrochloride by FC reagent method (15 g/ml, λmax 734 nm) Figure 3.12:- Calibration curve for Naltrexone hydrochloride at 734 nm by FC reagent method Table 3.36:- Data for absorption spectrum of Naltrexone hydrochloride for FC reagent method (Drug concentration = 15 g/ml) Wavelength (nm) Absorbance
35 148 P a g e International Standard Serial Number (ISSN): Table 3.37:- Result of calibration curve for Naltrexone hydrochloride by FC reagent method Concentration Absorbance (μg/ml) Mean ± S.D* % CV ± ± ± ± ± ± *Average of three determinations. Table 3.38:- Optical characteristic and precision by FC reagent method Parameter FC reagent method max (nm) 734 Beer s law limits ( g/ml) (c) 5-25 Molar absorptivity (lit. mol -1 cm -1 ) x 10 4 Limit of Detection (LOD/ mcgml -1 ) Limit of Quantification (LOQ/ mcgml -1 ) Sandell s sensitivity ( g/ml abs unit) Regression equation (Y*) Slope (b) Intercept (a) x 10-4 Standard error of estimation (Se) Correlation coefficient (r) % RSD Range of Errors** Confidence limit with 0.05 level Confidence limit with 0.01 level % Error in bulk Samples*** 0.31 *Y=bC+a, where C is the concentration of Naltrexone hydrochloride in g/ml and Y is the absorbance at the respective maximum absorbency, **Average of eight determination, ***Average of three determination.
36 149 P a g e International Standard Serial Number (ISSN): Table 3.39:- Assay and Recovery of Naltrexone hydrochloride in Pharmaceutical dosage form (Tablet) by FC reagent method Sample Labeled amount (mg) Amount obtained* (mg) Proposed Method Reference method (UV Method by cosolvancy) % recovery T T T1 and T2 are tablets from different manufactures, *Average of 5 determinations (50 mg of Naltrexone hydrochloride was added and recovered). Table 3.40:- Determination of accuracy of Naltrexone hydrochloride Level of % Recovery 80 % 100 % 120 % Amount Of drug in formulation* (mg) *Pre-analyzed sample taken from T 1 and T 2. Amount of standard drug added (mg) Total amount of drug found (mg) % Recovery of pure drug
MEDAK DIST. ANDHRA PRADESH STATE, INDIA. Research Article RECEIVED ON ACCEPTED ON
Page67 Available Online through IJPBS Volume 1 Issue 2 APRIL- JUNE 2011 SIMPLE QUANTITATIVE METHOD DEVELOPMENT AND VALIDATION OF VALSARTAN IN PUREFORM AND PHARMACEUTICAL DOSAGE FORMS BYUV SPECTROSCOPY
More informationDEVELOPMENT AND VALIDATION OF COLORIMETRIC METHODS FOR THE DETERMINATION OF RITONAVIR IN TABLETS
Int. J. Chem. Sci.: 8(1), 2010, 711-715 DEVELOPMENT AND VALIDATION OF COLORIMETRIC METHODS FOR THE DETERMINATION OF RITONAVIR IN TABLETS R. PRIYADARSINI *, V. NIRAIMATHI, T. SARASWATHY, V. GOPI and R.
More information4. VISIBLE SPECTROPHOTOMETRIC DETERMINATION OF. Fulvestrant is primarily used in the treatment of hormone receptor
121 4. VISIBLE SPECTROPHOTOMETRIC DETERMINATION OF FULVESTRANT 4.1 INTRODUCTION Fulvestrant is primarily used in the treatment of hormone receptor positive metastatic breast cancer in post-menopausal women
More informationScholars Research Library
Available online at www.scholarsresearchlibrary.com Scholars Research Library Der Pharmacia Lettre, 2010, 2(2): 294-299 (http://scholarsresearchlibrary.com/archive.html) ISSN 0975-5071 USA CODEN: DPLEB4
More informationPHARMA SCIENCE MONITOR AN INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES
PHARMA SCIENCE MONITOR AN INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES ULTRA VIOLET AND DERIVATIVE SPECTROPHOTOMETRIC METHODS FOR ESTIMATION OF METOLAZONE IN PHARMACEUTICALS Shobha Manjunath, S. Appala
More informationJournal of Chemical and Pharmaceutical Research
Available on line www.jocpr.com Journal of Chemical and Pharmaceutical Research J. Chem. Pharm. Res., 2010, 2(5): 45-51 ISSN No: 0975-7384 CODEN(USA): JCPRC5 Simultaneous U.V. Spectrophotometric estimation
More information210 J App Pharm Vol. 6; Issue 2: ; April, 2014 Mustafa et al, 2014
210 J App Pharm Vol. 6; Issue 2: 210-216; April, 2014 Mustafa et al, 2014 Original Research Article DEVELOPMENT OF UV SPECTROPHOTOMETRIC METHODS AND VALIDATION FOR ESTIMATION OF TRAMADOL HYDROCHLORIDE
More informationpharmaceutical formulations. Anagliptin shows absorption maximum at 246 nm and obeys beer s law in the
ISSN: 0975-766X CODEN: IJPTFI Available Online through Research Article www.ijptonline.com DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR ESTIMATION OF ANAGLIPTIN IN TABLET DOSAGE FORM BY U.V. SPECTROPHOTOMETRIC
More informationDevelopment and validation of UV-visible spectrophotometric method for estimation of rifapentine in bulk and dosage form
Available online at www.derpharmachemica.com Scholars Research Library Der Pharma Chemica, 2013, 5(2):251-255 (http://derpharmachemica.com/archive.html) ISSN 0975-413X CODEN (USA): PCHHAX Development and
More informationIJRPC 2011, 1(4) Rohan et al. ISSN: INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACY AND CHEMISTRY
INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACY AND CHEMISTRY Available online at www.ijrpc.com Research Article ABSORPTION CORRECTION METHOD AND SIMULTANEOUS EQUATION METHOD FOR THE SIMULTANEOUS ESTIMATION
More informationSpectrophotometric Estimation of Ganciclovir in Bulk Drug and its Formulation
International Journal of PharmTech Research CODEN (USA): IJPRIF ISSN : 974-434 Vol.2, No.2, pp 1264-1268, April-June 21 Spectrophotometric Estimation of Ganciclovir in Bulk Drug and its Formulation Prakash
More informationResearch Article Derivative Spectrophotometric Method for Estimation of Metformin Hydrochloride in Bulk Drug and Dosage Form
Research Article Derivative Spectrophotometric Method for Estimation of Metformin Hydrochloride in Bulk Drug and Dosage Form Gowekar NM, Lawande YS*, Jadhav DP, Hase RS and Savita N. Gowekar Department
More informationJ Pharm Sci Bioscientific Res (4): ISSN NO
Development and Validation of Analytical Methods for Simultaneous Estimation of Pregabalin and Amitriptyline Hydrochloride in their Combined Marketed Dosage form ABSTRACT: Nikhilkumar Patel, Gurjit Kaur,
More informationDevelopment and Validation for Simultaneous Estimation of Sitagliptin and Metformin in Pharmaceutical Dosage Form using RP-HPLC Method
International Journal of PharmTech Research CODEN (USA): IJPRIF ISSN : 0974-4304 Vol.5, No.4, pp 1736-1744, Oct-Dec 2013 Development and Validation for Simultaneous Estimation of Sitagliptin and Metformin
More informationfor Methotrexate. The result of analysis has been validated statistically and recovery studies confirmed the accuracy of
ISSN: 0975-766X CODEN: IJPTFI Available Online through Research Article www.ijptonline.com DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF LEFLUNOMIDE AND METHOTREXATE IN
More informationMethod Development and Validation of Emtricitabine in Bulk by UV Spectroscopy
Human Journals Research Article February 2019 Vol.:14, Issue:3 All rights are reserved by Gandi Anusha et al. Method Development and Validation of Emtricitabine in Bulk by UV Spectroscopy Keywords: Emtricitabine,
More informationAvailable Online through Research Article
ISSN: 0975-766X Available Online through Research Article www.ijptonline.com SPECTROPHOTOMETRIC METHODS FOR THE DETERMINATION OF FROVATRIPTAN SUCCINATE MONOHYDRATE IN BULK AND PHARMACEUTICAL DOSAGE FORMS
More informationValidated UV Spectrophotometric Method Development And Stability Studies Of Acamprosate Calcium In Bulk And Tablet Dosage Form
International Journal of PharmTech Research CODEN (USA): IJPRIF ISSN : 0974-4304 Vol.5, No.3, pp 1241-1246, July-Sept 2013 Validated UV Spectrophotometric Method Development And Stability Studies Of Acamprosate
More informationIJPAR Vol.3 Issue 4 Oct-Dec-2014 Journal Home page:
IJPAR Vol.3 Issue 4 Oct-Dec-2014 Journal Home page: ISSN: 2320-2831 Research article Open Access Method development and validation of tenofovir disoproxil fumerate and emtricitabine in combined tablet
More informationAvailable online Research Article
Available online www.jocpr.com Journal of Chemical and Pharmaceutical Research, 2016, 8(3):289-294 Research Article ISSN : 0975-7384 CODEN(USA) : JCPRC5 Simultaneous UV-spectrophotometric estimation of
More informationValidated Spectrophotometric Method for Simultaneous Estimation of Atorvastatin and Nicotinic acid in Combined Pharmaceutical dosage form
International Journal of PharmTech Research CODEN (USA): IJPRIF ISSN : 974-434 Vol.4, No.3, pp 999-3, July-Sept Validated Spectrophotometric Method for Simultaneous Estimation of Atorvastatin and Nicotinic
More informationRP- HPLC and Visible Spectrophotometric methods for the Estimation of Meropenem in Pure and Pharmaceutical Formulations
International Journal of ChemTech Research CODEN( USA): IJCRGG ISSN : 0974-4290 Vol. 3, No.2, pp 605-609, April-June 2011 RP- HPLC and Visible Spectrophotometric methods for the Estimation of Meropenem
More informationSpectrophotometric Method for Estimation of Sitagliptin Phosphate in Bulk...
Spectrophotometric Method for Estimation of Sitagliptin Phosphate in Bulk... I J P F A International Science Press Spectrophotometric Method for Estimation of Sitagliptin Phosphate in Bulk and Tablet Dosage
More informationRP-HPLC Analysis of Temozolomide in Pharmaceutical Dosage Forms
Asian Journal of Chemistry Vol. 22, No. 7 (2010), 5067-5071 RP-HPLC Analysis of Temozolomide in Pharmaceutical Dosage Forms A. LAKSHMANA RAO*, G. TARAKA RAMESH and J.V.L.N.S. RAO Department of Pharmaceutical
More informationDevelopment and validation of spectrophotometric method for simultaneous estimation of Sumatriptan and Naproxen sodium in tablet dosage form
Available online at www.pelagiaresearchlibrary.com Der Pharmacia Sinica, 2010, 1 (1): 36-41 Development and validation of spectrophotometric method for simultaneous estimation of Sumatriptan and Naproxen
More informationRP-HPLC Method Development and Validation of Abacavir Sulphate in Bulk and Tablet Dosage Form
RP-HPLC Method Development and Validation of Abacavir Sulphate in Bulk and Tablet Dosage Form S. LAVANYA* 1, SK. MANSURA BEGUM 1, K. NAGAMALLESWARA RAO 2, K. GAYATHRI DEVI 3 Department of pharmaceutical
More informationISSN (Print)
Scholars Academic Journal of Pharmacy (SAJP) Sch. Acad. J. Pharm., 2014; 3(3): 240-245 Scholars Academic and Scientific Publisher (An International Publisher for Academic and Scientific Resources) www.saspublisher.com
More informationA HIGH PERFORMANCE LIQUID CHROMATOGRAPHIC ASSAY FOR LERCANIDIPINE HYDROCHLORIDE
Int. J. Chem. Sci.: 6(1), 2008, 441-446 A HIGH PERFORMANCE LIQUID CHROMATOGRAPHIC ASSAY FOR LERCANIDIPINE HYDROCHLORIDE S. APPALA RAJU, ARVIND B. KARADI and SHOBHA MANJUNATH HKES s College of Pharmacy,
More informationPelagia Research Library
Available online at www.pelagiaresearchlibrary.com Der Pharmacia Sinica, 2015, 6(5):8-14 ISSN: 0976-8688 CODEN (USA): PSHIBD Simultaneous UV-spectrophotometric estimation of bromhexine hydrochloride and
More informationInternational Journal of Pharma and Bio Sciences DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR THE ESTIMATION OF STRONTIUM RANELATE IN SACHET
International Journal of Pharma and Bio Sciences RESEARCH ARTICLE ANALYTICAL CHEMISTRY DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR THE ESTIMATION OF STRONTIUM RANELATE IN SACHET K.MYTHILI *, S.GAYATRI,
More information10 Kadam V. N. et al. Ijppr.Human, 2014; Vol. 1(2): 10-21 (Research Article) DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR SIMULTANEOUS ESTIMATION OF VOGLIBOSE, GLIMEPIRIDE AND METFORMIN HYDROCHLORIDE
More informationThe present manuscript describes simple, sensitive, rapid, accurate, precise and cost effective First derivative
ISSN: 0975-766X CODEN: IJPTFI Available Online through Research Article www.ijptonline.com DEVELOPMENT AND VALIDATION OF FIRST ORDER DERIVATIVE SPECTROPHOTOMETRIC METHOD FOR SIMULTANEOUS ESTIMATION OF
More informationDevelopment and Validation of Stability Indicating HPTLC Method for Estimation of Seratrodast
ARC Journal of Pharmaceutical Sciences (AJPS) Volume 2, Issue 3, 2016, PP 15-20 ISSN 2455-1538 DOI: http://dx.doi.org/10.20431/2455-1538.0203004 www.arcjournals.org Development and Validation of Stability
More informationDevelopment and Validation of a New Uv Method for the Analysis of Rebamipide
International Journal of PharmTech Research CODEN (USA): IJPRIF ISSN : 0974-4304 Vol.3, No.3, pp1270-1274, July-Sept 2011 Development and Validation of a New Uv Method for the Analysis of Rebamipide Praveen
More informationIJRPC 2013, 3(1) Gandhi et al ISSN: INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACY AND CHEMISTRY
INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACY AND CHEMISTRY Available online at www.ijrpc.com Research Article DEVELOPMENT OF UV-SPECTROPHOTOMETRIC METHOD FOR THE QUANTITATIVE ESTIMATION OF OFLOXACIN AND
More informationInternational Journal of Pharma and Bio Sciences
International Journal of Pharma and Bio Sciences RESEARCH ARTICLE PHARMACEUTICAL ANALYSIS DEVELOPMENT AND VALIDATION OF LIQUID CHROMATOGRAPHIC METHOD FOR ESTIMATION OF ESCITALOPRAM OXALATE IN TABLET DOSAGE
More informationInt. J. Pharm. Sci. Rev. Res., 31(1), March April 2015; Article No. 46, Pages:
Research Article Development and Validation of First Order Derivative UV Spectrophotometric Method For Simultaneous Estimation of Nebivolol and Cilnidipine in Pharmaceutical Formulation Ms. Krupa Chaitanya
More informationDevelopment of a Validated RP-HPLC Method for the Analysis of Citicoline Sodium in Pharmaceutical Dosage Form using Internal Standard Method
Research Article Development of a Validated RP-HPLC Method for the Analysis of Citicoline Sodium in Pharmaceutical Dosage Form using Internal Standard Method * S. M. Sandhya, G. Jyothisree, G. Babu Department
More informationDEVELOPMENT OF UV SPECTROPHOTOMETRIC METHOD FOR THE ESTIMATION OF EZETIMIBE FROM TABLET FORMULATION
Int. J. Chem. Sci.: 13(2), 2015, 1051-1056 ISSN 0972-768X www.sadgurupublications.com DEVELOPMENT OF UV SPECTROPHOTOMETRIC METHOD FOR THE ESTIMATION OF EZETIMIBE FROM TABLET FORMULATION KHEMCHAND GUPTA
More informationUV SPECTROPHOTOMETRIC METHOD DEVELOPMENT AND VALIDATION FOR THE DETERMINATION OF ATENOLOL AND LOSARTAN POTASSIUM BY Q-ANALYSIS
UV SPECTROPHOTOMETRIC METHOD DEVELOPMENT AND VALIDATION FOR THE DETERMINATION OF ATENOLOL AND LOSARTAN POTASSIUM BY Q-ANALYSIS *K.V.LALITHA 1, R.KIRANJYOTHI 2, B.PADMA 3 ABSTRACT This communication describe
More informationPelagia Research Library
Available online at www.pelagiaresearchlibrary.com Der Pharmacia Sinica, 2015, 6(1):6-10 ISSN: 0976-8688 CODEN (USA): PSHIBD Validated RP-HPLC method for simultaneous estimation of metformin hydrochloride
More informationDEVELOPMENT AND VALIDATION OF SPECTROPHOTOMETRIC METHOD FOR DETERMINATION OF METOPROLOL SUCCINATE
Page224 Research Article Pharmaceutical Sciences DEVELOPMENT AND VALIDATION OF SPECTROPHOTOMETRIC METHOD FOR DETERMINATION OF METOPROLOL SUCCINATE S. A. Pagar*, D.M.Shinkar 1, R.B.Saudagar 2 *,1 Department
More informationDevelopment and validation of UV spectrophotometric estimation of lisinopril dihydrate in bulk and tablet dosage form using area under curve method
Journal of Innovations in Applied Pharmaceutical Sciences www.jiapsonline.com ISSN: 2455-5177 Research article Development and validation of UV spectrophotometric estimation of lisinopril dihydrate in
More informationAvailable online Research Article
Available online www.jocpr.com Journal of Chemical and Pharmaceutical Research, 2015, 7(9):951-960 Research Article ISSN : 0975-7384 CODEN(USA) : JCPRC5 Analytical method development and validation for
More informationJournal of Chemical and Pharmaceutical Research, 2013, 5(1): Research Article
Available online www.jocpr.com Journal of Chemical and Pharmaceutical Research, 2013, 5(1):180-184 Research Article ISSN : 0975-7384 CODEN(USA) : JCPRC5 A simple and sensitive RP-HPLC method for estimation
More informationScholars Research Library. Der Pharmacia Lettre, 2016, 8 (3): (
Available online at www.scholarsresearchlibrary.com Scholars Research Library Der Pharmacia Lettre, 2016, 8 (3):261-266 (http://scholarsresearchlibrary.com/archive.html) ISSN 0975-5071 USA CODEN: DPLEB4
More informationJournal of Chemical and Pharmaceutical Research, 2012, 4(9): Research Article
Available online www.jocpr.com Journal of Chemical and Pharmaceutical Research, 2012, 4(9):4342-4351 Research Article ISSN : 0975-7384 CODEN(USA) : JCPRC5 Development and validation of new colorimetric
More informationInternational Journal of Advances in Pharmacy and Biotechnology Vol.3, Issue-1, 2017, 1-7 Research Article Open Access.
I J A P B International Journal of Advances in Pharmacy and Biotechnology Vol.3, Issue-1, 2017, 1-7 Research Article Open Access. ISSN: 2454-8375 DEVELOPMENT AND VALIDATION OF FIRST ORDER DERIVATIVE SPECTROPHOTOMETRIC
More informationDEVELOPMENT OF RP-HPLC METHOD FOR ESTIMATION OF DROTAVERINE HYDROCHLORIDE IN PHARMACEUTICAL FORMULATIONS
Int. J. Chem. Sci.: 6(4), 2008, 2055-2061 DEVELOPMENT OF RP-HPLC METHOD FOR ESTIMATION OF DROTAVERINE HYDROCHLORIDE IN PHARMACEUTICAL FORMULATIONS B. S. SASTRY a, S. GANANADHAMU and G. DEVALA RAO K. V.
More informationCorresponding Author:
Adv J Pharm Life sci Res, 2017 5;3:1-8 ISSN 2454 3535 (On-line) RP-HPLC Method for Estimation of Mupirocin in Bulk and Pharmaceutical Formulation S.K.Attar 1 *, M.S.Kalshetti 2, N. A. Jadhao 3, N. R. Patel
More informationJournal of Chemical and Pharmaceutical Research
Available on line www.jocpr.com Journal of Chemical and Pharmaceutical Research ISSN No: 0975-7384 CODEN(USA): JCPRC5 J. Chem. Pharm. Res., 2011, 3(1):138-144 Simultaneous RP HPLC determination of Latanoprost
More informationWorld Journal of Pharmaceutical Research
World Journal of Pharmaceutical ReseaRch Volume 3, Issue 3, 4527-4535. Research Article ISSN 2277 715 DEVELOPMENT AND VALIDATION OF STABILITY INDICATING HPLC METHOD FOR ESTIMATION OF RAMOSETRON Zarana
More informationDevelopment and validation of analytical methods for estimation of imatinib mesylate in bulk and solid dosage forms by UV spectroscopy
Available online at www.scholarsresearchlibrary.com Scholars Research Library Der Pharmacia Lettre, 2015, 7 (3):214-220 (http://scholarsresearchlibrary.com/archive.html) ISSN 0975-5071 USA CODEN: DPLEB4
More informationRP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR CILOSTAZOL IN TABLET DOSAGE FORM
IJPAR Vol.5 Issue 4 Oct - Dec -2016 Journal Home page: ISSN:2320-2831 Research article Open Access RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR CILOSTAZOL IN TABLET DOSAGE FORM *1 M. Swapna *, 2 M.Vijay
More information36 J App Pharm Vol. 6; Issue 1: 36-42; January, 2014 Rao et al., 2014
36 J App Pharm Vol. 6; Issue 1: 36-42; January, 2014 Rao et al., 2014 Original Research Article SIMPLE AND RAPID LIQUID CHROMATOGRAPHIC METHOD FOR REAL-TIME QUANTIFICATION OF NAPROXEN / ESOMEPRAZOLE MAGNESIUM
More informationDevelopment and Validation of Area Under Curve Method for Simultaneous Estimation of Thiocolchicoside and Lornoxicam in Tablet Dosage Form
Development and Validation of Area Under Curve Method for Simultaneous Estimation of Thiocolchicoside and Lornoxicam in Tablet Dosage Form ABSTRACT: A Patel* 1, B Shah 2 1 Research Scholar, Dpt. of Pharmacy,
More informationSimultaneous estimation of Metformin HCl and Sitagliptin in drug substance and drug products by RP-HPLC method
International Journal of Chemical and Pharmaceutical Sciences 2017, Mar., Vol. 8 (1) ISSN: 0976-9390 IJCPS Simultaneous estimation of Metformin HCl and Sitagliptin in drug substance and drug products by
More informationDevelopment, Estimation and Validation of Lisinopril in Bulk and its Pharmaceutical Formulation by HPLC Method
ISSN: 0973-4945; CODEN ECJAO E- Chemistry http://www.e-journals.net 2012, 9(1), 340-344 Development, Estimation and Validation of Lisinopril in Bulk and its Pharmaceutical Formulation by PLC Method V.
More informationPelagia Research Library
Available online at www.pelagiaresearchlibrary.com Der Pharmacia Sinica, 2014, 5(5):91-98 ISSN: 0976-8688 CODEN (USA): PSHIBD A novel RP-HPLC method development and validation of Perindopril Erbumine in
More informationSIMULTANEOUS ESTIMATION OF VALSARTAN AND HYDROCHLOROTHIAZIDE IN TABLETS BY RP-HPLC METHOD
170 Original Article SIMULTANEOUS ESTIMATION OF VALSARTAN AND HYDROCHLOROTHIAZIDE IN TABLETS BY RP-HPLC METHOD *Lakshmana Rao A, 1 Bhaskara Raju V *V.V. Institute of Pharmaceutical Sciences, Gudlavalleru,
More informationAsian Journal of Pharmaceutical Analysis and Medicinal Chemistry Journal home page:
Research Article CODEN: AJPAD7 ISSN: 2321-0923 Asian Journal of Pharmaceutical Analysis and Medicinal Chemistry Journal home page: www.ajpamc.com ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF GEFITINIB
More informationSimultaneous UV Spectrophotometric Method For Estimation Of Ebastine And Montelukast Sodium In Tablet Dosage Form By Q-Ratio Method
International Journal of ChemTech Research CODEN( USA): IJCRGG ISSN : 0974-4290 Vol.5, No.1, pp 47-55, Jan-Mar 2013 Simultaneous UV Spectrophotometric Method For Estimation Of Ebastine And Montelukast
More informationReverse Phase HPLC Analysis of Atomoxetine in Pharmaceutical Dosage Forms
Asian Journal of Chemistry Vol. 21, No. 2 (2009), 829-833 Reverse Phase HPLC Analysis of Atomoxetine in Pharmaceutical Dosage Forms B.V.V.S. JAGADEESH, S. SATYANARAYANA RAJU, V.JAYATHIRTHA RAO and J.V.L.N.
More informationDEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR ASSAY AND DISSOLUTION OF METOPROLOL SUCCINATE EXTENDED RELEASE TABLETS
Innovare Academic Sciences International Journal of Pharmacy and Pharmaceutical Sciences ISSN- 0975-1491 Vol 6, Issue 5, 2014 Original Article DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR ASSAY AND
More informationAMERICAN JOURNAL OF BIOLOGICAL AND PHARMACEUTICAL RESEARCH
AMERICAN JOURNAL OF BIOLOGICAL AND PHARMACEUTICAL RESEARCH e-issn - 2348-2184 Print ISSN - 2348-2176 Journal homepage: www.mcmed.us/journal/ajbpr VALIDATED RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF
More informationUV Spectrophotometric Estimation of Alprazolam by Area Under Curve And First Order Derivative Methods in Bulk and Pharmaceutical Dosage Form
Available online at www.scholarsresearchlibrary.com Scholars Research Library Der Pharmacia Lettre, 2016, 8 (5):105-110 (http://scholarsresearchlibrary.com/archive.html) ISSN 0975-5071 USA CODEN: DPLEB4
More informationAvailable online at Scholars Research Library
Available online at www.scholarsresearchlibrary.com Scholars Research Library Der Pharmacia Lettre, 2015, 7 (3):157-161 (http://scholarsresearchlibrary.com/archive.html) ISSN 0975-5071 USA CODEN: DPLEB4
More informationHyderabad, India. Department of Pharmaceutical Chemistry, Glocal University, Saharanpur, India.
International Journal On Engineering Technology and Sciences IJETS RP-HPLC Method development and validation for the Simultaneous Estimation of Metformin and Empagliflozine in Tablet Dosage Form Shaik
More informationREVERSE PHASE HPLC METHOD FOR THE ANALYSIS OF ALFUZOSIN HYDROCHLORIDE IN PHARMACEUTICAL DOSAGE FORMS
Int. J. Chem. Sci.: 6(1), 2008, 399-404 REVERSE PHASE HPLC METHOD FOR THE ANALYSIS OF ALFUZOSIN HYDROCHLORIDE IN PHARMACEUTICAL DOSAGE FORMS S. APPALA RAJU, ARVIND B. KARADI and SHOBHA MANJUNATH HKES s
More informationGuntur, India. *Corres. Mobile:
International Journal of PharmTech Research CODEN (USA): IJPRIF ISSN : 0974-4304 Vol.4, No.4, pp 1508-1512, Oct-Dec 2012 Development Of Simple And Sensitive Visible Spectrophotometric Methods For The Determination
More informationInternational Journal of Medicine and Pharmaceutical Research. International Journal of Medicine and Pharmaceutical Research
International Journal of Medicine and Pharmaceutical Research Journal Home Page: www.pharmaresearchlibrary.com/ijmpr Research Article Open Access Development and Validation of RP-HPLC Method for the Estimation
More informationDEVELOPMENT AND VALIDATION OF AN UV- SPECTROPHOTOMETRIC METHOD FOR THE ESTIMATION OF FLUOXETINE IN PURE AND TABLET DOSAGE FORMS
IJPSR (2014), Vol. 5, Issue 8 (Research Article) Received on 18 February, 2014; received in revised form, 10 April, 2014; accepted, 13 June, 2014; published 01 August, 2014 DEVELOPMENT AND VALIDATION OF
More informationMETHOD DEVELOPMENT AND VALIDATION BY RP-HPLC FOR ESTIMATION OF ZOLPIDEM TARTARATE
WORLD JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES Ramalakshmi et al. SJIF Impact Factor 6.647 Volume 7, Issue 2, 1010-1018 Research Article ISSN 2278 4357 METHOD DEVELOPMENT AND VALIDATION BY RP-HPLC
More informationDevelopment and Validation of RP-HPLC Method for the Estimation of Gemigliptin
Human Journals Research Article September 2018 Vol.:13, Issue:2 All rights are reserved by Hajera Khan et al. Development and Validation of RP-HPLC Method for the Estimation of Gemigliptin Keywords: Gemigliptin,
More informationJournal homepage:
243 Print ISSN - Acta Biomedica Scientia e - ISSN - 2348-2168 Print ISSN - 2348-215X Journal homepage: www.mcmed.us/journal/abs METHOD DEVELOPMENT AND VALIDATION OF NALTREXONE HCl ANDBUPROPION HCl IN BULK
More informationStability indicating RP-HPLC method development and validation of Etizolam and Propranolol hydrochloride in pharmaceutical dosage form
World Journal of Pharmaceutical Sciences ISSN (Print): 2321-3310; ISSN (Online): 2321-3086 Published by Atom and Cell Publishers All Rights Reserved Available online at: http://www.wjpsonline.org/ Original
More informationSimultaneous Estimation of Gemcitabine Hydrochloride and Capecitabine Hydrochloride in Combined Tablet Dosage Form by RP-HPLC Method
ISSN: 0973-4945; CODEN ECJHAO E- Chemistry http://www.e-journals.net 2011, 8(3), 1212-1217 Simultaneous Estimation of Gemcitabine Hydrochloride and Capecitabine Hydrochloride in Combined Tablet Dosage
More informationNEW SPECTROPHOTOMETRIC METHODS FOR THE QUANTITATIVE ESTIMATION OF EZOGABINE IN FORMULATIONS
INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACY AND CHEMISTRY Available online at www.ijrpc.com Research Article NEW SPECTROPHOTOMETRIC METHODS FOR THE QUANTITATIVE ESTIMATION OF EZOGABINE IN FORMULATIONS
More informationCHAPTER INTRODUCTION OF DOSAGE FORM AND LITERATURE REVIEW
132 CHAPTER 6 DEVELOPMENT AND VALIDATION OF A STABILITY-INDICATING RP-HPLC METHOD FOR SIMULTANEOUS DETERMINATION OF PARACETAMOL, TRAMADOL HYDROCHLORIDE AND DOMPERIDONE IN A COMBINED DOSAGE FORM 6.1 INTRODUCTION
More informationDevelopment and validation of UV and RP-HPLC method for estimation of Nepafenac in bulk drug and opthalmic formulation
Research Article Development and validation of UV and RP-HPLC method for estimation of Nepafenac in bulk drug and opthalmic formulation Sadhana Rajput*, Chhaya Shrimali, Madhuri Baghel Quality Assurance
More informationMethod Development and Validation for the Estimation of Saroglitazar in Bulk and Pharmaceutical Dosage Form by RP-HPLC
Original Research Method Development and Validation for the Estimation of Saroglitazar in Bulk and Pharmaceutical Dosage Form by RP-HPLC Hanumantha Rao K 1, Lakshmana Rao A 2,*, Chandra Sekhar KB 3 1 Assistant
More informationJournal of Chemical and Pharmaceutical Research, 2018, 10(2): Research Article
Available online www.jocpr.com Journal of Chemical and Pharmaceutical Research, 2018, 10(2):84-90 Research Article ISSN : 0975-7384 CODEN(USA) : JCPRC5 Development and Validation of Q-Absorbance Ratio
More informationInternational Journal of Innovative Pharmaceutical Sciences and Research
International Journal of Innovative Pharmaceutical Sciences and Research www.ijipsr.com SIMULTANEOUS ESTIMATION OF PARACETAMOL AND IBUPROFEN IN BULK AND PHARMACEUTICAL DOSAGE FORM BY USING UV SPECTROPHOTOMETRIC
More informationJournal of Pharmacreations
Journal of Pharmacreations ISSN: 2348-6295 Pharmacreations Vol.5 Issue 1 Jan- Mar- 2018 Journal Home page: www.pharmacreations.com Research article Open Access Method development and validation of apixaban
More informationDr. Dilip G. Maheshwariet al, Asian Journal of Pharmaceutical Technology & Innovation, 04 (17); 2016; Research Article
Asian Journal of Pharmaceutical Technology & Innovation ISSN: 2347-8810 Research Article Received on: 29-03-2016 Accepted on: 31-03-2016 Published on: 15-04-2016 Development and Validation of UV Spectrometric
More informationAvailable online Research Article
Available online www.jocpr.com Journal of Chemical and Pharmaceutical Research, 2016, 8(1):171-176 Research Article ISSN : 0975-7384 CODEN(USA) : JCPRC5 Reverse phase high performance liquid chromatography
More informationTentu Nageswara Rao et al. / Int. Res J Pharm. App Sci., 2012; 2(4): 35-40
International Research Journal of Pharmaceutical and Applied Sciences Available online at www.irjpas.com Int. Res J Pharm. App Sci., 2012; 2(4):35-40 Research Article Estimation of Fesoterodine fumarate
More informationResearch and Reviews: Journal of Pharmacy and Pharmaceutical Sciences
Research and Reviews: Journal of Pharmacy and Pharmaceutical Sciences A Validated Spectrophotometric Method for Determination of Paliperidone Palmitate in Bulk Drug and its Pharmaceutical Dosage Form.
More informationDEVELOPMENT AND VALIDATION OF RP-HPLC METHOD ESTIMATION OF TOLVAPTAN IN BULK PHARMACEUTICAL FORMULATION
http://www.rasayanjournal.com Vol.4, No.1 (2011), 165-171 ISSN: 0974-1496 CODEN: RJCABP DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR AND ITS PHARMACEUTICAL FORMULATION V. Kalyana Chakravarthy * and
More information0 9 : >?! 0 (.56± E
*! "# $%! &,!! + ) *$ ( '# 0 -. 3 " # (& 208!1.2 0 -. / 1 1 7$%!$ ) 8 3 9: 3. - & 4 10 4 1.770! (-/< 0.30 >?!@ A # - -/< 30-3 ;! 8 ;. >? B$ 0.9999 B 0 -. 3 '#! 0.71 ± 99.3 - #! 0.7 ± 99.7 3 7$% standard
More informationDevelopment and Validation of a UV-Spectrophotometric Method for Quantification of Atorvastatin in Tablets
Journal of PharmaSciTech 0; ():4-40 Research Article Development and Validation of a UV-Spectrophotometric Method for Quantification of Atorvastatin in Tablets Ghanty S*, Sadhukhan N, Mondal A Gupta College
More informationVALIDATED RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF DEXAMETHASONE AND GRANISETRON IN COMBINED DOSAGE FORMS
INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACY AND CHEMISTRY Available online at www.ijrpc.com Research Article VALIDATED RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF DEXAMETHASONE AND GRANISETRON IN COMBINED
More informationDEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR QUANTITATIVE ANALYSIS TOLBUTAMIDE IN PURE AND PHARMACEUTICAL FORMULATIONS
Int. J. Chem. Sci.: 11(4), 2013, 1607-1614 ISSN 0972-768X www.sadgurupublications.com DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR QUANTITATIVE ANALYSIS TOLBUTAMIDE IN PURE AND PHARMACEUTICAL FORMULATIONS
More informationComparative study of analytical method development of fluconazole in tablets and capsule by ultraviolet spectrophotometric method
Research Article Comparative study of analytical method development of fluconazole in tablets and capsule by ultraviolet spectrophotometric method Shital S. Patil*, Ubhale Ravindra, Yeole Tejal, Tayade
More informationDEVELOPMENT AND VALIDATION UV SPECTROPHOTOMETRIC METHOD FOR DETERMINATION OF ATENOLOL IN PURE MATERIALS AND PHARMACEUTICAL DOSAGE
Page8179 Indo American Journal of Pharmaceutical Research, 2017 ISSN NO: 2231-6876 DEVELOPMENT AND VALIDATION UV SPECTROPHOTOMETRIC METHOD FOR DETERMINATION OF ATENOLOL IN PURE MATERIALS AND PHARMACEUTICAL
More informationDEVELOPMENT AND VALIDATION OF NEW HPLC METHOD FOR THE ESTIMATION OF PALIPERIDONE IN PHARMACEUTICAL DOSAGE FORMS
ISSN: 0974-1496 e-issn: 0976-0083 CODEN: RJCABP http://www.rasayanjournal.com http://www.rasayanjournal.co.in DEVELOPMENT AND VALIDATION OF NEW HPLC METHOD FOR THE ESTIMATION OF PALIPERIDONE IN PHARMACEUTICAL
More informationInternational Journal of Drug Research and Technology
Int. J. Drug Res. Tech. 2016, Vol. 6 (3), 115-119 ISS 2277-1506 International Journal of Drug Research and Technology Available online at http://www.ijdrt.com riginal Research Paper SPECTRPHTMETRIC DETERMIATI
More informationDepartment Of Quality Assurance Techniques, Modern College of Pharmacy Nigdi, Pune Maharashtra, India
IJPSR (2013), Vol. 4, Issue 1 (Research Article) Received on 20 September, 2012; received in revised form, 06 November, 2012; accepted, 22 December, 2012 DEVELOPMENT AND VALIDATION OF A STABILITY INDICATING
More information438 Full Text Available On
International Journal of Universal Pharmacy and Bio Sciences 2(3): May-June 2013 INTERNATIONAL JOURNAL OF UNIVERSAL PHARMACY AND BIO SCIENCES Pharmaceutical Sciences Research Article!!! Received: 17-05-2013;
More informationResearch Article Simultaneous Estimation of DL-Methionine and Pyridoxine Hydrochloride in Tablet Dosage Form by RP-HPLC
Research Article Simultaneous Estimation of DL-Methionine and Pyridoxine Hydrochloride in Tablet Dosage Form by RP-HPLC Shinde Prashanti 1 *, Mane Aruna 2, Palled Mahesh 1, Bhat AR 1 and Karagane Swapna
More information